An AllTrials project

NCT02839200: A reported trial by Idorsia Pharmaceuticals Ltd.

This trial has reported on time, in line with the regulations.

Full data

Full entry on ClinicalTrials.gov NCT02839200
Title Multi-center, Double-blind, Randomized, Placebo-controlled, Active-reference, Parallel-group, Polysomnography Dose-response Study to Assess the Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder
Results Status Reported
ACT or pACT? This is what FDAAA officially calls a "probable Applicable Clinical Trial"
Start date Oct. 4, 2016
Completion date April 12, 2017
Required reporting date April 12, 2020, midnight
Actual reporting date March 6, 2020
Date last checked at ClinicalTrials.gov Feb. 9, 2024
Days late None